Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-30), European Medical Solutions's 12-1 Month Momentum % is -10.93%.
The industry rank for European Medical Solutions's 12-1 Month Momentum % or its related term are showing as below:
STU:AS00's 12-1 Month Momentum % is ranked better than 56.45% of 1357
companies
in the Biotechnology industry
Industry Median: -22.78
vs STU:AS00: -10.93
European Medical Solutions (STU:AS00) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
European Medical Solutions 12-1 Month Momentum % Related Terms
STU:AS00 vs VRTX, REGN, RVMD: 12-1 Month Momentum % Comparison
For the Biotechnology subindustry, European Medical Solutions's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions 12-1 Month Momentum % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's 12-1 Month Momentum % falls into.
European Medical Solutions (STU:AS00) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -10.93% mean?
European Medical Solutions (STU:AS00) has a 12-1 Month Momentum % of -10.93% as of Aug. 30, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on European Medical Solutions and its competitors. According to the industry distribution chart, European Medical Solutions ranks #591 out of 1357 companies in the Biotechnology industry, placing it in the top 43.6%.
Is European Medical Solutions' 12-1 Month Momentum % too high?
European Medical Solutions' current 12-1 Month Momentum % is -10.93%. Based on the distribution chart, European Medical Solutions ranks #591 out of 1357 companies in the Biotechnology industry, which is above the industry midpoint. Overall, European Medical Solutions has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' 12-1 Month Momentum % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #591 out of 1357 companies for 12-1 Month Momentum %. This puts European Medical Solutions in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Biotechnology company?
A good 12-1 Month Momentum % depends on the Biotechnology industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current 12-1 Month Momentum % is -10.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
Based on GuruFocus' analysis, European Medical Solutions (STU:AS00) is currently considered Possible Value Trap. The stock's GF Value™ is €7.49, compared to a current price of €3.60 — trading 51.9% below its estimated fair value. The current 12-1 Month Momentum % is -10.93%. European Medical Solutions' overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current 12-1 Month Momentum % is -10.93% as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €3.60 is trading 51.9% below its estimated GF Value™ of €7.49.
GuruFocus considers European Medical Solutions to be Possible Value Trap.
Key valuation signals for STU:AS00:
12-1 Month Momentum %: -10.93%
GF Value™: €7.49 vs. price of €3.60 (51.9% below fair value)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
51GF Score
Get the complete analysis for STU:AS00
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 
